Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
This clinical trial update describes care considerations for patients with prostate cancer and outlines plans for prospective procurement of…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 study of the PARG inhibitor ETX-19477 in patients with advanced solid malignancies is currently recruiting, including breast cance…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
A clinical trial is evaluating a plasma exoRNA-based liquid biopsy to diagnose clinically significant prostate cancer and is currently recru…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients [Phase 2]
Phase 2 clinical trial evaluating the effect of a novel hormone therapy combined with local treatment. Treatment decisions are guided by PSM…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) [NA]
This clinical trial update describes the RTIRE study combining radiation therapy and irreversible electroporation for intermediate-risk pros…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy [Phase 2]
Phase 2 clinical trial evaluating enzalutamide in combination with the ADC PDS01ADC for PET-positive recurrent prostate cancer in patients n…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer [Phase 2]
A Phase 2 study is evaluating in-home versus in-clinic cancer therapy delivery for Black men with locally advanced, biochemically recurrent,…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration
This clinical trial update describes implementing a new algorithm for HRR gene mutation testing in metastatic prostate cancer patients using…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease [Phase 2]
A Phase 2 clinical trial evaluating intensified 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer with low PSMA exp…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating Rezvilutamide with radical prostatectomy and metastasis-directed therapy for oligometastatic prostate cancer; curre…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Effect Of Trendelenburg Position And Pneumoperitoneum On Optic Nerve Sheath Diameter In Robot-Assisted Prostatectomy
This clinical trial study investigates the effect of steep Trendelenburg position with pneumoperitoneum on optic nerve sheath diameter durin…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: The Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Level, Complication Development in Transrectal Ultrasonography Guided Prostate Biopsy [NA]
A clinical trial investigating whether intrarectal ice application before TRUS-guided prostate biopsy reduces pain, anxiety, cortisol levels…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer [NA]
The update describes a trial using molecular imaging-guided radiation dose escalation to recurrent disease sites and de-escalation to uninvo…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial of tinengotinib (TT-00420) in combination with standard treatments for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study [Phase 3]
This Phase 3 trial update describes the ERADICATE study, which investigates adding darolutamide to androgen deprivation therapy after surger…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring [Phase 2]
Phase 2 clinical trial evaluating whether green tea extract can slow progression of prostate cancer in men under close monitoring; the study…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A mLifestyle Intervention for Men on Androgen Deprivation Therapy for PCa [NA]
This entry reports on a clinical trial evaluating a lifestyle intervention for men on androgen deprivation therapy for prostate cancer. The …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing Moderately Ultra Hypofractionated Radiation Treatments for Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating moderately ultra hypofractionated radiation schedules for post-operative prostate cancer. The study…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization [Phase 2]
Phase II study to evaluate the safety and efficacy of Prostatic Artery Embolization. The trial includes conditions of prostate cancer and be…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment [NA]
The document indicates that a clinical study evaluating the 18F-rhPSMA-7.3 radiotracer for diagnosing prostate cancer after focal gland trea…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
A clinical trial update examining mechanisms, predictors, and social determinants of cardiotoxicity in prostate cancer patients.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy [Phase 2]
A Phase 2 neoadjuvant trial examining Lu-177-PSMA-617 in patients with high-risk localized prostate cancer undergoing radical prostatectomy.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions [NA]
Clinical trial update on dose escalation in prostate radiotherapy using an MR-Linac delivered in two fractions; recruiting participants.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial (PRO-BOOST-N) evaluating Prostate-First versus combined Prostate and nodal dose escalation in PSMA PET-stag…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors [NA]
A Rutgers-sponsored clinical trial aims to improve coordination between cancer care teams and primary care for complex cancer survivors. The…